Albert Einstein College of Medicine, Bronx, NY, USA.
Headache. 2014 Feb;54(2):260-8. doi: 10.1111/head.12287. Epub 2014 Jan 16.
Tension-type headache is highly prevalent in the general population and is a consistent if not frequent cause of visits to acute care settings. Analgesics such as nonsteroidal anti-inflammatory drugs, acetaminophen, and salicylates are considered first-line therapy for treatment of tension-type headache. For patients who present to an acute care setting with persistent tension-type headache despite analgesic therapy, it is not clear which parenteral agent should be administered. We performed a systematic review of the medical literature to determine whether parenteral therapies other than salicylates or nonsteroidals are efficacious for acute tension-type headache.
We performed a systematic review of Medline, EMBASE, CINAHL, Google scholar, and the Cochrane Central Registry of Controlled Trials from inception through August, 2012 using the search terms "tension-type headache" and "parenteral or subcutaneous or intramuscular or intravenous." Our goal was to identify randomized trials in which one parenteral treatment was compared to another active comparator or to placebo for the acute relief of tension-type headache. Parenteral was defined as intravenous, intramuscular, or subcutaneous administration. We only included studies that distinguished tension-type headache from other primary headache disorders, such as migraine. The primary outcome for this review was measures of efficacy one hour after medication administration. Data abstraction was performed by two authors. Disagreements were resolved by a third author. We assessed the internal validity of trials using the Cochrane Collaboration risk of bias tool. Because of the small number of trials identified, and the substantial heterogeneity among study design and medications, we decided that combining data and reporting summary statistics would serve no useful function. The results of individual studies are presented using Number Needed to Treat (NNT) with 95%CI when dichotomous outcomes were available and continuous outcomes otherwise.
Our search returned 640 results. One hundred eighty-seven abstracts were reviewed, and 8 studies involving 486 patients were included in our analysis. The most common reasons for exclusion of abstracts were no assessment of acute pain relief, use of nonparenteral medications only, and no differentiation of headache type. Risk of bias ranged from low to high. The following medications were more effective than placebo for acute pain (NNT, 95%CI): metamizole (4, 2-26), chlorpromazine (4, 2-26), and metoclopramide (2, 1-3). The combination of metoclopramide + diphenhydramine was superior to ketorolac (4, 2-8) The following medications were not more effective than placebo: mepivacaine, meperidine + promethazine, and sumatriptan.
Various parenteral medications other than salicylates or nonsteroidals provide acute relief of tension-type headache. Comparative efficacy studies are needed.
紧张型头痛在普通人群中发病率很高,是急性医疗场所就诊的常见原因,如果不是经常的原因的话。非甾体抗炎药、对乙酰氨基酚和水杨酸盐等镇痛药被认为是治疗紧张型头痛的一线药物。对于在接受镇痛治疗后仍持续出现紧张型头痛而到急性医疗场所就诊的患者,尚不清楚应给予哪种注射药物。我们对医学文献进行了系统评价,以确定除水杨酸盐或非甾体类药物以外的其他注射药物是否对急性紧张型头痛有效。
我们对 Medline、EMBASE、CINAHL、Google Scholar 和 Cochrane 对照试验中心注册数据库进行了系统评价,检索词为“紧张型头痛”和“注射或皮下或肌内或静脉”。我们的目标是确定将一种注射治疗与另一种活性对照或安慰剂比较,以急性缓解紧张型头痛的随机试验。注射定义为静脉、肌内或皮下给药。我们只纳入了将紧张型头痛与偏头痛等其他原发性头痛障碍区分开来的研究。本综述的主要结局是药物治疗后 1 小时的疗效评估。由两名作者进行数据提取。意见分歧由第三名作者解决。我们使用 Cochrane 协作风险偏倚工具评估试验的内部有效性。由于确定的试验数量较少,且研究设计和药物之间存在很大的异质性,因此我们认为合并数据和报告汇总统计数据没有任何作用。当存在二分类结局时,使用需要治疗的人数(NNT)及其 95%CI 报告个别研究的结果,否则使用连续结局。
我们的搜索返回了 640 个结果。审查了 187 篇摘要,纳入了 8 项涉及 486 名患者的研究进行分析。排除摘要的最常见原因是未评估急性疼痛缓解、仅使用非注射药物以及未区分头痛类型。偏倚风险从低到高不等。以下药物对急性疼痛的疗效优于安慰剂(NNT,95%CI):美洛昔康(4,2-26)、氯丙嗪(4,2-26)和甲氧氯普胺(2,1-3)。甲氧氯普胺+苯海拉明的组合优于酮咯酸(4,2-8)以下药物的疗效不比安慰剂好:甲哌卡因、哌替啶+异丙嗪和舒马曲坦。
除水杨酸盐或非甾体类药物以外的各种注射药物均可缓解紧张型头痛的急性发作。需要进行比较疗效的研究。